Liver Diseases  >>  Pegintron/Rebetol Combo Pack (peginterferon alfa-2b + ribavirin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegintron/Rebetol Combo Pack (peginterferon alfa-2b + ribavirin) / Merck (MSD)
NCT00160251 / 2005-001264-31: Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)

Completed
2
357
US
Boceprevir (BOC), SCH 503034, PegIntron (PEG), Ribavirin (RBV)
Merck Sharp & Dohme LLC
Chronic Hepatitis C
07/07
07/07
NCT00367887: A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects

Completed
2
246
US
Peg-Intron, REBETOL, HCV 796
Wyeth is now a wholly owned subsidiary of Pfizer, ViroPharma
Hepatitis C
07/08
07/08

Download Options